Villaruz Liza C

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 179 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Phase I Trial of ATR Inhibitor Elimusertib with FOLFIRI in Advanced or Metastatic Gastrointestinal Malignancies (ETCTN 10406)

Anuradha Krishnamurthy,Hong Wang,John C. Rhee,Diwakar Davar,Ryan H. Moy,Lee Ratner,Susan M. Christner,Julianne L. Holleran, Joshua Deppas, Carina Sclafani,John C. Schmitz, Steve Gore,Edward Chu,Christopher J. Bakkenist,Jan H. Beumer,Liza C. Villaruz

Cancer Chemotherapy and Pharmacologyno. 1 (2025): 1-12

Cited0Views0WOSBibtex

Development, Review, and Activation of Thoracic Oncology Investigator-Initiated Trials

David E Gerber, Claire R Wynters,Tanushree Prasad, Ronny K Schnel, Song Zhang,Thomas E Stinchcombe,Liza C Villaruz, Joshua M Bauml,Wade T Iams,Tejas Patil,Stephen V Liu,Leora Horn, John M Hudak,D Ross Camidge

Clinical cancer research an official journal of the American Association for Cancer Researchno. 6 (2025): 1103-1108

Cited0Views0WOSBibtex

Osimertinib Vs. Afatinib in 1L Therapy of Atypical EGFR-mutated Metastatic Non-Small Cell Lung Cancer (mnsclc): A Multi-Institution, Real-World Survival Analysis

Adam Barsouk,Omar Elghawy, Alex Watts, Lauren Reed-Guy, William Tompkins, Krishna Chandrasekhara, Connor B Grady, Wade Iams, Fangdi Sun,Geoffrey Liu,Devalben Patel, Jorge J Nieva,Kristen A Marrone,Vamsidhar Velcheti, Stephen V Liu,Tejas Patil,Jared Weiss, William Schwartzman,Liza C Villaruz, Amanda Hermann,Dara L Aisner, Wei-Ting Hwang, D Ross Camidge,Lova Sun, Aditi Puri Singh,Roger B Cohen,Charu Aggarwal, Corey J Langer, Melina E Marmarelis

Lung cancer (Amsterdam, Netherlands) (2025): 108551-108551

Cited0Views0WOSBibtex

Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung Cancer

Mehmet Altan,Gilberto Lopes,T. Jeroen N. Hiltermann,Ramaswamy Govindan,Liza C. Villaruz,Emiliano Calvo,Martin J. Edelman,Muhammad Furqan,Joel Neal,Enriqueta Felip,Jennifer W. Carlisle,John V. Heymach,Roisin Eilish O'Cearbhaill,Marjorie Zauderer,Michael Chisamore, Ellie Corigliano, Ioanna Eleftheriadou,Stefan Zajic,Ben Jenkins, Sophia Goodison,Sunil Suchindran, Natalia Ramos-Hernandez, Nidale Tarek,Adam J. Schoenfeld

CLINICAL CANCER RESEARCH（2025）

Cited0Views0WOSBibtex

Concurrent and Consolidative Carboplatin Plus Nab-Paclitaxel or Paclitaxel in Locally Advanced NSCLC A Multicenter, Randomized Clinical Trial

Yuanyuan Zhang,Aaron M Laine,Puneeth Iyengar,Kenneth D Westover,Jonathan E Dowell,Randall S Hughes,Alana Christie, Townes Mickel,Albert Attia,Liza Villaruz,Yuhchyau Chen,David R Spigel,Mark A Socinski, Robert D Timmerman,David E Gerber

International Journal of Radiation OncologyBiologyPhysics (2025)

Cited0Views0WOSBibtex

Phase 1 Studies of the Indenoisoquinolines LMP776 and LMP744 in Patients with Solid Tumors and Lymphomas

Geraldine O’Sullivan Coyne,Shivaani Kummar, Larry V. Rubinstein,Deborah Wilsker, Nancy Moore, Murielle Hogu,Richard Piekarz, Joe Covey,Jan H. Beumer,Katherine V. Ferry-Galow,Liza C. Villaruz,Melinda G. Hollingshead,Julianne L. Holleran, Joshua J. Deppas,Yves Pommier, Brian Ko, Barry C. Johnson, Ralph E. Parchhment, Percy Ivy, James H. Doroshow, Alice P. Chen

Cancer Chemotherapy and Pharmacologyno. 1 (2025): 1-15

Cited0Views0WOSBibtex

Brief Report: Phase Ii Clinical Trial of Atezolizumab in Advanced Non-Small Cell Lung Cancer Patients Previously Treated with Pd-1-Directed Therapy

Dylan Fortman,Hong Wang,Robert Vanderweele,Terry Evans,James G. Herman,John Rhee,Vincent Reyes,Brian Mclaughlin,Antoinette Wozniak,Ashwin Somasundaram, Tarek Mekhail,Mark A. Socinski,Katja Schulze,Liza C. Villaruz

CLINICAL LUNG CANCER（2025）

Cited0Views0WOSBibtex

670P Phase I Trial of the Delta-Like Ligand-3 (DLL3)/CD3 IgG-Like T Cell Engager BI 764532 in Patients (pts) with DLL3-positive Tumors: Updated Data

M. Wermke,V. Gambardella,Y. Kuboki, E. Felip,M.F. Sanmamed,O. Alese,C.M. Sayehli,E. Arriola Aperribay,J. Wolf,L. Villaruz,M. Studeny,M. Bouzaggou, X. Fang,D. Morgensztern

Annals of Oncology（2024）

Cited0Views0Bibtex

A Phase I/II Study of Davutamig (REGN5093), a METxMET Bispecific Antibody, in Patients with MET-altered, Advanced Non-Small Cell Lung Cancer (ansclc): Trial in Progress Update

M-j. Ahn,B. C. Cho,T. M. Kim,J-y. Han, C. Kim,B. Shim, A. Drilon,G. Blumenschein,L. Villaruz,J. E. Gray,J-l. Pujol,H. Lena,D. Moro-Sibilot, J. Perez, D. A. Modi, J. S. Park, S. Patel, S. Li, E. Kim,H. Magnan

ANNALS OF ONCOLOGY (2024): S1673-S1674

Cited0Views0Bibtex

721Tip A Phase I/II Study of Davutamig (REGN5093), a MET×MET Bispecific Antibody, in Patients with MET-altered, Advanced Non-Small Cell Lung Cancer (ansclc): Trial in Progress Update

M-J. Ahn,B.C. Cho,T.M. Kim,J-Y. Han, C. Kim,B. Shim, A. Drilon,G. Blumenschein,L. Villaruz,J.E. Gray,J-L. Pujol,H. Lena,D. Moro-Sibilot,J. Perez, D.A. Modi, J.S. Park,S. Patel, S. Li, E. Kim,H. Magnan

Annals of Oncology (2024): S1673-S1674

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Assistant Professor

Papers共 179 篇Author StatisticsCo-AuthorSimilar Experts